Major Depressive Disorder

In Thursday’s Plenary Session at CROI 2019, David Blast, from the University of Liverpool highlighted the drug interactions in the older HIV population, the need for more searchable databases, and which...

In Thursday’s Plenary Session at CROI 2019, David Blast, from the University of Liverpool highlighted the drug interactions in the older HIV population, the need for more searchable databases, and which...

Several biomarkers obtained through non-invasive means could help to predict the development of non-alcoholic fatty liver disease in patients living with HIV (PWH), according to recent research.

Several biomarkers obtained through non-invasive means could help to predict the development of non-alcoholic fatty liver disease in patients living with HIV (PWH), according to recent research.

Several biomarkers obtained through non-invasive means could help to predict the development of non-alcoholic fatty liver disease in patients living with HIV (PWH), according to recent research.

Certain antiretroviral therapy (ART) drugs could be associated with an increased risk of end-stage liver disease (ESLD) in patients with HIV.

Certain antiretroviral therapy (ART) drugs could be associated with an increased risk of end-stage liver disease (ESLD) in patients with HIV.

Certain antiretroviral therapy (ART) drugs could be associated with an increased risk of end-stage liver disease (ESLD) in patients with HIV.

The FibroScan-AST (FAST) score has been shown to be effective for the risk assessment of non-alcoholic hepatic steatosis (NASH) in patients without HIV, but its effectiveness in HIV+ patients is currently...

The FibroScan-AST (FAST) score has been shown to be effective for the risk assessment of non-alcoholic hepatic steatosis (NASH) in patients without HIV, but its effectiveness in HIV+ patients is currently...